M

ore than 10 years after its discovery, a special type of stem cell is being put to the test.

In 2014 scientists in Japan launched the world’s first clinical trials using the cells, called induced pluripotent stem cells, and now scientists in the United States are in the run-up to this country’s first trial. iPS cells, as they are known, start as another type of cell — often blood or skin — before scientists coax them back into becoming stem cells. From there, researchers can then steer them to differentiate into another type of cell, building a vast wave of hope for the cells’ therapeutic potential.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

X